SleepWell Trade

Trend-Following Backtester · Guide · backtest 한국어

equity · US

Century Therapeutics, Inc. backtest

10 trend-following strategies were compared on the full daily history of Century Therapeutics, Inc.. 10 beat buy-and-hold CAGR; ADX / DI 방향성 ranks first by Sharpe, matching the main backtester. The return/drawdown alternative is Keltner 채널 돌파 (CAGR 37.0%, MDD -24.5%).

Data 2021-06-18 ~ 2026-07-31daily bars 1,285 (5.1 years)Costs 0.5%Venue XNASMonthly snapshot 2026-07-31

Results by strategy

10 of 10 beat buy and hold (CAGR -37.8%, drawdown -98.8%).

Sharpe leader (same as main): ADX / DI 방향성 — CAGR 44.5%, MDD -37.0%, Sharpe 1.04, 10% exposure.

Return/drawdown alternative: Keltner 채널 돌파 — CAGR is 82.3%p higher than buy and hold, while drawdown improves by 61.8%p (CAGR 37.0%, MDD -24.5%, exposure 6%).

The alternative must retain 75% of buy-and-hold CAGR, improve drawdown by at least 20% and 5 percentage points, and stay below 95% exposure; the ranking weights return retention 60% and drawdown improvement 40%.

Strategy · parametersCAGRMDDSharpeCalmarTotalTradesExposure
ADX / DI 방향성
period=25, threshold=29
44.5%-37.0%1.041.206.6x610%
Keltner 채널 돌파
emaPeriod=17, atrPeriod=17, mult=3.1
37.0%-24.5%1.011.515.0x46%
볼린저 밴드 돌파
n=43, k=3.5
34.8%-37.0%0.900.944.6x612%
SMA 크로스오버
fast=53, slow=92
27.7%-49.8%0.730.563.5x825%
Donchian 채널 돌파
entryN=95, exitN=43
24.6%-41.2%0.690.603.1x318%
EMA 크로스오버
fast=14, slow=123
22.9%-46.6%0.660.492.9x519%
ROC 모멘텀
n=93, threshold=0.09
23.0%-56.2%0.660.412.9x2221%
Supertrend
period=19, mult=4.8
18.1%-53.6%0.570.342.3x729%
Parabolic SAR
step=0.01, maxStep=0.14
-11.1%-86.2%0.10-0.130.5x7040%
MACD
fast=11, slow=34, signal=15
-20.7%-90.8%-0.03-0.230.3x6652%
Buy and hold-37.8%-98.8%-0.17-0.380.1x1100%
0.1 1x 2022 2023 2024 2025 2026 ADX / DI 방향성Buy and hold
ADX / DI 방향성: Solid strategy line versus dashed buy-and-hold line. Log scale.
0% -25% -49% -74% -99% 2022 2023 2024 2025 2026 Buy and holdADX / DI 방향성
ADX / DI 방향성 maximum drawdown -37.0% (2026-01-27 → 2026-02-05), recovered after 41 days.

Rules of the top strategy

Looks at both the direction and the strength of the trend; holds only in a strong uptrend.

Method and caveats

Past performance does not guarantee future returns. Parameters were selected on the same full-history sample using sharpe over 40 trials per strategy, so results contain in-sample bias. 0.5% trading costs are included; taxes, slippage and rejected orders are not.
Re-run the same setupMore US assetsAll asset reports

Read next